The efficacy and safety of Janus kinase inhibitors in adults with rheumatoid arthritis: a systematic review and cumulative meta-analysis.
Janus kinase (JAK) inhibitors have been subject to multiple safety warnings recently. Patient treatment decisions should be evidence-based using the most up-to-date data on the efficacy and safety of JAK inhibitors. In a systematic review and cumulative meta-analysis (CMA), Medl…